Apex expects rising trend in generic drugs to continue

Generic drugs have emerged as a substitute to the high-priced patented drugs. Ape said, in its 2022 annual report, that the rising trend of generic drugs is expected to continue driven by an ageing population, rising affluence and increasing life expectancy.

KUALA LUMPUR: Apex Healthcare Bhd is eyeing further growth in the generic drugs segment of the healthcare and pharmaceutical industry.

Generic drugs have emerged as a substitute to the high-priced patented drugs.